PanGenomic Health Inc. is a Canadian biotech company advancing diagnostic technology with innovative tools and techniques for detecting diseases, including cancer, with a focus on personalized healthcare.

PanGenomic Health Inc. has reported a negative earnings per share of -0.13 CAD for the latest quarter, but has shown improvement from the previous year’s loss, amidst a resilient biotech sector.

PanGenomic Health Inc. is a Canadian biotechnology company advancing diagnostic innovation with cutting-edge tools that promise to revolutionize disease detection and personalized healthcare.